期刊文献+

肾细胞癌浸润淋巴细胞的杀伤肿瘤活性测定及表型分析 被引量:4

A study of antitumor activity and phenotypes of tumor infiltrating Iymphocytes in human renal cell carcinoma
原文传递
导出
摘要 采用Whiteside方法从19例RCC中成功地分离到17例TIL,经19天培养,TIL数量平均达1.04×10^(11)个细胞。杀伤自体肿瘤活性为57.87±5.88%,对Raji细胞的杀伤活性为37.39±10.88%,两组间比较差异有非常显著性(P<0.01)。明显高于外周血淋巴细胞(PBL)的杀伤肿瘤活性(22.39±8.84%)。TIL中CD_3和CD8细胞分别为69.93±6.80%及40.21±6.80%,均明显高于PBL中的CD3和CD_8细胞(P<0.01)。TIL对K562细胞的杀伤活性为26.89±12.79%,提示活化的TIL有显著的杀伤肿瘤活性,且对自体肿瘤细胞的杀伤活性更为显著,其杀伤活性主要由T淋巴细胞介导。 Tumor infiltrating lymphoctytes(TIL)suspensions were successfully isolated with the Whiteside method from 19 renal cell carcinoma(RCC).After cultured for an average of 19 days(13 ̄28 days),the mean TIL recovery was 1.04 ×10 ̄(11) pertumor.The cytotoxic activity of TII against autologous tumor cells was signifi cantly higher than that against Raji cells(P< 0.01).The latter was however significantly higher than that of peripheral blood lymphocytes(PBL)(P< 0.01). Phenotype studies showed that the mean percentage of CD_3 cells was 69. 93 % and CD8 cells 40.21% both of which were significantly higher than those in PBL(P<0.01). The results denoted that activated TIL has relatively specific antitumor activity against autologous RCC,mediated mainly by T lymphocytes, and the antitumor activity is stronger than that of PBL.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 1996年第2期73-76,共4页 Chinese Journal of Urology
关键词 肾肿瘤 T淋巴细胞 免疫疗法 Kidney neoplasms,Carcinoma,T lympocytes,Immunotherapy
  • 相关文献

同被引文献21

  • 1侯建国,曹广文,李光辉,钱松溪,夏广彬,廖国强,郑家富,张汉升,郑影.联合应用TIL和IL-2治疗肾癌[J].中华泌尿外科杂志,1996,17(5):279-281. 被引量:2
  • 2King S C, Pollack L A, LiJ, KingJ B, Master V A. Continued increase in incidence of renal cell carcinoma, especially in young patients and highgradedisease , United States 2001 to 2010[J].J Urol, 2014,191: 1665- 1670. 被引量:1
  • 3Thoenes W, Storkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas roncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics[J]. Pathol Res Pract,1986,181:125-143. 被引量:1
  • 4Xu X, Hou v , Yin X,Bao L, Tang Av Song Lv et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor[J]. Cell, 2012, 148: 886-895. 被引量:1
  • 5Pena-Llopis S, Vega-Rubin-de-Cells S, Liao A, Leng N, Pavia-Jimenez A. Wang S. et al. BAP1 loss defines a new class of renal cell carcinoma[J]. Nat Genet.2012, 44:751-759. 被引量:1
  • 6SjolundJ ,Johansson M, Manna S, Norin C. Pietras A, Beckman S. et al. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and vivo[J]J Clin Invest,2008,118:217-228. 被引量:1
  • 7Tan X. He S, Han v, Yu v, XiaoJ, Xu D, et al. Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients[J]. Cancer Cell Int , 2013,13: 20. 被引量:1
  • 8Huang D.Ding Y.Luo W M,Bender S.Qian C N,Kort E, et al. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo[J]. Caner Res.2008,68:81-88. 被引量:1
  • 9Sourbier Cv Lindner V.Lang Hv Agouni Av Schordan E, Danilin S, et al. The phosphorinositide 3-kinase/ AkT pathway: a new target in human renal cell carcinoma therapy[J]. Cancer Res,2006,66:5130-5142. 被引量:1
  • 10Tan X. Zhai Y. Chang W, HouJ, He S, Lin L. et al. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma[J]. IntJ Cancer, 2008,123: 1080- 1088. 被引量:1

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部